Modulating neuroinflammation and cognitive function in postoperative cognitive dysfunction via CCR5 ‐ GPCRs ‐Ras‐ MAPK pathway targeting with microglial EVs
CNS Neuroscience & Therapeutics · 2024
DOI: 10.1111/cns.14924 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2024. Verfasst von Zheng Qi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Pain and Perioperative Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Microglia, Receptors, CCR5, Neuroinflammatory Diseases, Postoperative Cognitive Complications. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Aims
Postoperative cognitive dysfunction (POCD) is prevalent among the elderly, characterized primarily by cognitive decline after surgery. This study aims to explore how extracellular vesicles (EVs) derived from BV2 microglial cells, with and without the C‐C chemokine receptor type 5 (CCR5), affect neuroinflammation, neuronal integrity, and cognitive function in a POCD mouse model.
Methods
We collected EVs from LPS‐stimulated BV2 cells expressing CCR5 (EVs M1 ) and from BV2 cells with CCR5 knockdown (EVs M1‐CCR5 ). These were administered to POCD‐induced mice. Protein interactions between CCR5, G‐protein‐coupled receptors (GPCRs), and Ras were analyzed using structure‐based docking and co‐immunoprecipitation (Co‐IP). We assessed the phosphorylation of p38 and Erk, the expression of synaptic proteins PSD95 and MAP2, and conducted Morris Water Maze tests to evaluate cognitive function.
Results
Structure‐based docking and Co‐IP confirmed interactions between CCR5, GPR, and Ras, suggesting a CCR5‐GPCRs‐Ras‐MAPK pathway involvement in neuroinflammation. EVs M1 heightened neuroinflammation, reduced synaptic integrity, and impaired cognitive function in POCD mice. In contrast, EVs M1‐CCR5 reduced neuroinflammatory markers, preserved synaptic proteins, enhanced dendritic spine structure, and improved cognitive outcomes.
Conclusion
EVs M1 induced neuroinflammation via the CCR5‐GPCRs‐Ras‐MAPK pathway, with EVs M1‐CCR5 showing protective effects on POCD progression, suggesting a new therapeutic strategy for POCD management via targeted modification of microglial EVs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Pain and Perioperative Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Biobank of The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
- Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
ORCID-Profile: Jian-Jun Yang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Qi, Z., Peng, J., Wang, H., Wang, L., Su, Y., Ding, L., Cao, B., Zhao, Y., Xing, Q., & Yang, J. J. (2024). Modulating neuroinflammation and cognitive function in postoperative cognitive dysfunction via CCR5 ‐ GPCRs ‐Ras‐ MAPK pathway targeting with microglial EVs. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.14924
Vancouver
Qi Z, Peng J, Wang H, Wang L, Su Y, Ding L, et al. Modulating neuroinflammation and cognitive function in postoperative cognitive dysfunction via CCR5 ‐ GPCRs ‐Ras‐ MAPK pathway targeting with microglial EVs. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.14924
BibTeX
@article{Qi2024,
author = {Qi, Zheng and Peng, Junlin and Wang, Haitao and Wang, Li and Su, Yu and Ding, Lan and Cao, Bin and Zhao, Yingying and Xing, Qinghe and Yang, Jian-Jun},
title = {Modulating neuroinflammation and cognitive function in postoperative cognitive dysfunction via CCR5 ‐ GPCRs ‐Ras‐ MAPK pathway targeting with microglial EVs},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
doi = {10.1111/cns.14924}
}
EUVIMED